An Amino Acid Mixture to Counteract Skeletal Muscle Atrophy: Impact on Mitochondrial Bioenergetics

Int J Mol Sci. 2024 May 31;25(11):6056. doi: 10.3390/ijms25116056.

Abstract

Skeletal muscle atrophy (SMA) is caused by a rise in muscle breakdown and a decline in protein synthesis, with a consequent loss of mass and function. This study characterized the effect of an amino acid mixture (AA) in models of SMA, focusing on mitochondria. C57/Bl6 mice underwent immobilization of one hindlimb (I) or cardiotoxin-induced muscle injury (C) and were compared with controls (CTRL). Mice were then administered AA in drinking water for 10 days and compared to a placebo group. With respect to CTRL, I and C reduced running time and distance, along with grip strength; however, the reduction was prevented by AA. Tibialis anterior (TA) muscles were used for histology and mitochondria isolation. I and C resulted in TA atrophy, characterized by a reduction in both wet weight and TA/body weight ratio and smaller myofibers than those of CTRL. Interestingly, these alterations were lightly observed in mice treated with AA. The mitochondrial yield from the TA of I and C mice was lower than that of CTRL but not in AA-treated mice. AA also preserved mitochondrial bioenergetics in TA muscle from I and C mice. To conclude, this study demonstrates that AA prevents loss of muscle mass and function in SMA by protecting mitochondria.

Keywords: amino acids; cardiotoxin; immobilization; sarcopenia.

MeSH terms

  • Amino Acids* / metabolism
  • Amino Acids* / pharmacology
  • Animals
  • Disease Models, Animal
  • Energy Metabolism* / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL*
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitochondria, Muscle / drug effects
  • Mitochondria, Muscle / metabolism
  • Mitochondria, Muscle / pathology
  • Muscle, Skeletal* / drug effects
  • Muscle, Skeletal* / metabolism
  • Muscle, Skeletal* / pathology
  • Muscular Atrophy* / drug therapy
  • Muscular Atrophy* / etiology
  • Muscular Atrophy* / metabolism
  • Muscular Atrophy* / pathology

Substances

  • Amino Acids

Grants and funding

This research received no external funding.